Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Although oral metronomic chemotherapy is often used in progressive pediatric solid malignant tumors, a literature review reveals that only small single-arm retrospective or phase 1 and 2 studies have been performed. Skepticism abounds because of the lack of level 1 evidence.

Related collections

Author and article information

Journal

Title: JAMA Oncology

Abbreviated Title: JAMA Oncol

Publisher: American Medical Association (AMA)

ISSN (Print): 2374-2437

Publication date Created: September 01 2017

Publication date (Print): September 01 2017

Volume: 3

Issue: 9

Page: 1222

Affiliations

[1 ]Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India

[2 ]Department of Pediatric Surgery, All India Institute of Medical Sciences, New Delhi, India

[3 ]Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India

[4 ]Department of Radiodiagnosis, All India Institute of Medical Sciences, New Delhi, India

[5 ]Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India

Article

DOI: 10.1001/jamaoncol.2017.0324

PMC ID: 5824286

PubMed ID: 28384657

SO-VID: d19a4d54-5fd3-41cf-a75d-1c809401902c

History

Data availability:

Comments

Comment on this article

scite_

Cited by 20

See all cited by

- Version 1
- Version 1

Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors : A Randomized Clinical Trial

Read this article at